failed trials

Hiker having trouble climbing mountain
Biotech

ALX Oncology doubles down as lead asset fails 2 phase 2 trials

Evorpacept failed to meet the primary endpoints of two head and neck cancer trials, causing the company to scrap further attempts in the indication.
Darren Incorvaia Apr 25, 2025 2:25pm
pivot change turnaround direction walk away

Sanofi's oral TNF asset misses mark in phase 2 psoriasis trial

Apr 24, 2025 4:46am
paint mural street artist spray paint woman painting

Mural's IL-2 flop triggers 90% staff reduction

Apr 15, 2025 9:33am
Sanofi

Sanofi's hopes for $1.1B Kymab drug dented after ph. 2 asthma fail

Apr 15, 2025 7:34am
boxing punch blow hit punching bag fight

Alzheon Alzheimer's drug knocked down in pivotal APOLLOE4 bout

Apr 10, 2025 8:48am
crash fall stock shares market economy down red arrow

Rallybio drops lead program as phase 2 data disappoint

Apr 8, 2025 8:52am